← Open Payments lookup

LETITIA LINCECUM: Open Payments

NPI 1346655289 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$720 in 20 payments from 8 companies in 2025. Trend: 2023 $301 · 2024 $534 · 2025 $720

Food & beverage: $720
CompanyPaymentsAmount
Ardelyx, Inc.4$256
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$153
Janssen Biotech, Inc.2$146
ABBVIE INC.6$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Amgen Inc.1$17
Abbott Laboratories1$15
Lilly USA, LLC1$15

Products named: IBSRELA, XIFAXAN, TREMFYA, UBRELVY, CAPLYTA, OTEZLA, VRAYLAR, FREESTYLE LIBRE 3.

Industry payments across LA — which companies pay providers there.